This inventor holds 3 USPTO granted patents. Top assignee: Ohio University. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Mark C McMills: Innovator in Biological Signaling
Introduction
Mark C McMills is a notable inventor based in Athens, OH (US). He has made significant contributions to the field of biological signaling through his innovative research and patents. With a total of 3 patents, McMills has established himself as a key figure in his area of expertise.
Latest Patents
His latest patents focus on imidazole and thiazole compositions that modify biological signaling. These compounds are characterized by complex general formulas that include various aliphatic, aromatic, and heteroaromatic groups. The patents describe how these compositions can be utilized in pharmaceutical applications to influence biological signaling processes or serve as reagents for biological assays.
Career Highlights
Mark C McMills is affiliated with Ohio University, where he continues to advance his research in biological signaling. His work has garnered attention for its potential applications in pharmaceuticals and biological research.
Collaborations
Some of his notable coworkers include Douglas Goetz and Stephen Bergmeier, who contribute to the collaborative research environment at Ohio University.
Conclusion
Mark C McMills exemplifies the spirit of innovation in the field of biological signaling, with his patents paving the way for future advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile